---
title: "$Recursion Pharmaceuticals(RXRX.US)$Tempus AI(TEM.US)$XTALPI(02228.HK)$Illumina(ILMN.US)There are co"
description: "$Recursion Pharmaceuticals(RXRX.US)$Tempus AI(TEM.US)$XTALPI(02228.HK)$Illumina(ILMN.US)There are countless drug R&D companies like RXRX in the US stock market. No matter how powerful AI is, it ca"
type: "topic"
locale: "en"
url: "https://longbridge.com/en/topics/38526884.md"
published_at: "2026-02-05T17:35:01.000Z"
author: "[空仓等暴跌](https://longbridge.com/en/profiles/19144251)"
---

# $Recursion Pharmaceuticals(RXRX.US)$Tempus AI(TEM.US)$XTALPI(02228.HK)$Illumina(ILMN.US)There are co

$Recursion Pharmaceuticals(RXRX.US)$Tempus AI(TEM.US)$XTALPI(02228.HK)$Illumina(ILMN.US)

There are countless drug R&D companies like RXRX in the US stock market. No matter how powerful AI is, it can't escape the risk of drug trial failures leading to sharp declines. Only data-selling TEM, Jingtai, and ILMN are the winners.

### Related Stocks

- [02228.HK - XTALPI](https://longbridge.com/en/quote/02228.HK.md)
- [ILMN.US - Illumina](https://longbridge.com/en/quote/ILMN.US.md)
- [TEM.US - Tempus AI](https://longbridge.com/en/quote/TEM.US.md)
- [RXRX.US - Recursion Pharmaceuticals](https://longbridge.com/en/quote/RXRX.US.md)

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.